-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – 200’S Series Novel Combinations (Dopamine Pathway) in Neurodegenerative Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - 200'S Series Novel Combinations (Dopamine Pathway) in Neurodegenerative Diseases report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. 200'S Series Novel Combinations (Dopamine Pathway) in...
-
Product Insights
NewNet Present Value Model: Compass Pathways Plc’s Psilocybin
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
NewLikelihood of Approval Analysis for Orthomyxoviridae Infections
Overview How likely is it that the drugs in Orthomyxoviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Orthomyxoviridae Infections Overview The family Orthomyxoviridae is defined by viruses that have...
-
Product Insights
NewLikelihood of Approval Analysis for Muscle Spasticity
Overview How likely is it that the drugs in Muscle Spasticity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Muscle Spasticity Overview Muscle spasticity is a condition that causes muscles to...
-
Product Insights
NewLikelihood of Approval Analysis for Varicella Zoster (HHV-3) Infections
Overview How likely is it that the drugs in Varicella Zoster (HHV-3) Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Varicella Zoster (HHV-3) Infections Overview Varicella-zoster virus (VZV), also known...
-
Product Insights
NewLikelihood of Approval Analysis for Eosinophilia
Overview How likely is it that the drugs in Eosinophilia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eosinophilia Overview Eosinophilia is defined as an increase of circulating eosinophils. The count...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Bile Duct Cancer
Overview How likely is it that the drugs in Metastatic Bile Duct Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Bile Duct Cancer Overview Cholangiocarcinoma, also known as bile...
-
Product Insights
NewLikelihood of Approval Analysis for Myeloproliferative Disorders
Overview How likely is it that the drugs in Myeloproliferative Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Myeloproliferative Disorders Overview MPDs are blood cancers caused by changes in the...
-
Product Insights
NewLikelihood of Approval Analysis for Vaginal Cancer
Overview How likely is it that the drugs in Vaginal Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vaginal Cancer Overview Vaginal cancer is a rare cancer that occurs in...
-
Product Insights
NewLikelihood of Approval Analysis for Thalassemia
Overview How likely is it that the drugs in Thalassemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thalassemia Overview Thalassemia is a group of inherited blood disorders that affect the...